Bay Colony Advisors’s Repligen RGEN Stock Holding History

Bay Colony Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4	Closed	–	–	742
2018 Q2	$0	Buy	+4	New	+$165	﹤0.01%	971

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bay Colony Advisors's RGEN Position: Q3 2018 in Review

Bay Colony Advisors sold out of Repligen (RGEN) in Q3 2018, closing a stake of 4 shares.

Bay Colony Advisors first reported a position in RGEN in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 201 funds tracked by Wall St. Rank hold RGEN as of Q3 2018.

Bay Colony Advisors reported no remaining Repligen position as of Q3 2018 after selling out during the quarter.
Bay Colony Advisors sold 4 Repligen shares in Q3 2018.
Bay Colony Advisors first reported a position in Repligen in Q2 2018 and held it in 1 quarter.
Bay Colony Advisors's Repligen position peaked at $0 in Q2 2018.
201 funds tracked by Wall St. Rank held Repligen as of Q3 2018.

Based on Bay Colony Advisors's 13F filing for Q3 2018, filed 5 Nov 2018.